Viral HS "Hacks" That Are Actually Hurting Your Skin
Just because it went viral doesn't mean it's safe for your skin. Here's why these popular HS trends do more harm than good.
Internal Medicine & Dermatology
Dr. Neela Moadab
Physician focused on medical dermatology
Bridging rheumatology and dermatology to champion your health, raise awareness, and empower you through shared knowledge.
Dermatology
Rheumatology
Whole-patient care
About
Growing up with atopic dermatitis in a rural area with limited access to specialized medical care, I experienced firsthand what it means to live with a chronic skin condition, navigating the daily struggles, social stigmas, and systemic challenges that come with it. This personal journey deeply informs my clinical empathy and dedication to patient-centered care.
I am a physician with a strong clinical and research interest in the intersection of rheumatology and dermatology. Skin findings often serve as the first visible sign of systemic autoimmune disease.
My primary areas of clinical interest include complex medical dermatology, specifically where cutaneous manifestations overlap with autoimmune, metabolic, and medication-related conditions.
Full biography →Clinical interests
- Complex medical dermatology
- Autoimmune & connective tissue disease
- Inflammatory skin disease (psoriasis, eczema, hidradenitis)
- Cutaneous drug reactions
- Skin cancer screening & prevention
- Dermatology in hospitalized patients
From the blog
All posts →
What a Positive ANA Test Result Actually Means
A positive ANA test is a starting point for investigation, not a diagnosis of lupus. What this screening test measures, why healthy people can test positive, and what to do next.
EADV 2026 Update: Tulisokibart Shows Promise in Phase 2b Hidradenitis Suppurativa Trial
Late-breaking Phase 2b results for tulisokibart (MK-7240), an investigational TL1A-blocking antibody for adults with moderate-to-severe hidradenitis suppurativa.